Neuronal uses of BMP-11

Details for Australian Patent Application No. 2005227386 (hide)

Owner Genetics Institute, LLC

Inventors Wozney, John M; Thies, Scott R.; Celeste, Anthony J.

Agent FB Rice

Pub. Number AU-A-2005227386

Parent 2003244613

Filing date 27 October 2005

Wipo publication date 17 November 2005

International Classifications

A61K 038/18 Medicinal preparations containing peptides - Growth factors

C12N 005/08 Undifferentiated human, animal or plant cells, e.g. cell lines -

C12N 015/12 Mutation or genetic engineering - Genes encoding animal proteins

C07K 014/51 Peptides having more than 20 amino acids

C12N 005/06 Undifferentiated human, animal or plant cells, e.g. cell lines -

Event Publications

10 November 2005 Complete Application Filed

17 November 2005 Application Open to Public Inspection

  Published as AU-A-2005227386

6 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005227387-Onselling pre paid mobile phone credit with extremely low minimum

2005227385-Use of benzodiazepines for treating autoimmune diseases induced by apoptosis